已收盤 08-07 16:00:00 美东时间
+0.200
+5.22%
Quanterix (QTRX) is scheduled to announce Q2 earnings results on Monday, August 10th, before market open. The consensus EPS Estimate is -$0.41 (+46.8% Y/Y) and the consensus Revenue Estimate is $37.46...
08-08 01:09
Quanterix Corporation (QTRX) added ~3% in the premarket on Wednesday after announcing that its Alzheimer’s test, LucentAD Complete, will be covered by Elevance Health’s (ELV) Anthem Blue Cross and Blu...
07-15 20:39
The announcements include: Anthem Blue Cross and Blue Shield eligible members will be the first commercially insured patients in the United States to benefit from medical policy coverage supporting blood-based biomarker testing for Alzheimer’s disease. Publication of new peer-reviewed study comparin...
07-15 04:34
Quanterix Corp. (NASDAQ:QTRX) shares surged 5.28% to $3.39 in pre-market trading on Wednesday, after the prior day’s 7.74% decline. What Investors Are Watching The after-hours rally follows Securities and Exchange Commission Tuesday filings disclosing outgoing Chief Financial Officer Vandana Sriram ...
06-24 16:39
Quanterix Corporation (NASDAQ:QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced the appointment of Jason Faessler as the Company's new Chief
06-09 20:07
2026年5月20日,北京英诺特生物技术股份有限公司(以下简称“英诺特”)与美国Quanterix Corporation(以下简称“Quanterix”)签署...
05-25 14:44
Quanterix Corporation (NASDAQ:QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that Vandana Sriram, its Chief Financial Officer ("CFO") will
05-13 04:12
今日重点评级关注:Citizens:维持BioCryst制药"跑赢大市"评级,目标价从25美元升至28美元;富国银行:维持曼恩凯德生物医疗"超配"评级,目标价从8美元升至10美元
05-08 12:05
TD Cowen analyst Dan Brennan maintains Quanterix (NASDAQ:QTRX) with a Hold and lowers the price target from $7 to $4.
05-08 03:46
Quanterix shares are trading lower after the company reported mixed Q1 financia...
05-07 22:57